Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1CNS 1

Conditions

Neuroendocrine Tumors 10Meningioma 6Neuroblastoma 5Carcinoid Tumor 5Medulloblastoma 3Paraganglioma 2Oncogenic osteomalacia 2Gastro-enteropancreatic neuroendocrine tumor 2Carcinoma, Neuroendocrine 2von Hippel-Lindau Disease 1Tumor Positron-Emission Tomography 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Prostatic Neoplasms 1Pinealoma 1Pheochromocytoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroma, Acoustic 1Neuroectodermal Tumors, Primitive 1Neoplasms, Neuroepithelial 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Ganglioneuroma 1Ganglioneuroblastoma 1Familial ependymoma 1

Interventions

Blood Specimen Collection 2gallium Ga 68 dotatate 1belzutifan 1Sunitinib 1Propranolol 1Magnetic Resonance Spectroscopy 1Exome Sequencing 1Bevacizumab 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × von Hippel-Lindau Disease × gallium Ga 68 dotatate × Clear all
NCT03001349 2021-02-15

68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated
4 enrolled
CNSEndocrineNET

von Hippel-Lindau Disease, Meningioma, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡